Cargando…

Development of FRET‐based high‐throughput screening for viral RNase III inhibitors

The class 1 ribonuclease III (RNase III) encoded by Sweet potato chlorotic stunt virus (CSR3) suppresses RNA silencing in plant cells and thereby counters the host antiviral response by cleaving host small interfering RNAs, which are indispensable components of the plant RNA interference (RNAi) path...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Linping, Saarela, Jani, Poque, Sylvain, Valkonen, Jari P.T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280029/
https://www.ncbi.nlm.nih.gov/pubmed/32436305
http://dx.doi.org/10.1111/mpp.12942
_version_ 1783543667334578176
author Wang, Linping
Saarela, Jani
Poque, Sylvain
Valkonen, Jari P.T.
author_facet Wang, Linping
Saarela, Jani
Poque, Sylvain
Valkonen, Jari P.T.
author_sort Wang, Linping
collection PubMed
description The class 1 ribonuclease III (RNase III) encoded by Sweet potato chlorotic stunt virus (CSR3) suppresses RNA silencing in plant cells and thereby counters the host antiviral response by cleaving host small interfering RNAs, which are indispensable components of the plant RNA interference (RNAi) pathway. The synergy between sweet potato chlorotic stunt virus and sweet potato feathery mottle virus can reduce crop yields by 90%. Inhibitors of CSR3 might prove efficacious to counter this viral threat, yet no screen has been carried out to identify such inhibitors. Here, we report a novel high‐throughput screening (HTS) assay based on fluorescence resonance energy transfer (FRET) for identifying inhibitors of CSR3. For monitoring CSR3 activity via HTS, we used a small interfering RNA substrate that was labelled with a FRET‐compatible dye. The optimized HTS assay yielded 109 potential inhibitors of CSR3 out of 6,620 compounds tested from different small‐molecule libraries. The three best inhibitor candidates were validated with a dose–response assay. In addition, a parallel screen of the selected candidates was carried out for a similar class 1 RNase III enzyme from Escherichia coli (EcR3), and this screen yielded a different set of inhibitors. Thus, our results show that the CSR3 and EcR3 enzymes were inhibited by distinct types of molecules, indicating that this HTS assay could be widely applied in drug discovery of class 1 RNase III enzymes.
format Online
Article
Text
id pubmed-7280029
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72800292020-06-10 Development of FRET‐based high‐throughput screening for viral RNase III inhibitors Wang, Linping Saarela, Jani Poque, Sylvain Valkonen, Jari P.T. Mol Plant Pathol Original Articles The class 1 ribonuclease III (RNase III) encoded by Sweet potato chlorotic stunt virus (CSR3) suppresses RNA silencing in plant cells and thereby counters the host antiviral response by cleaving host small interfering RNAs, which are indispensable components of the plant RNA interference (RNAi) pathway. The synergy between sweet potato chlorotic stunt virus and sweet potato feathery mottle virus can reduce crop yields by 90%. Inhibitors of CSR3 might prove efficacious to counter this viral threat, yet no screen has been carried out to identify such inhibitors. Here, we report a novel high‐throughput screening (HTS) assay based on fluorescence resonance energy transfer (FRET) for identifying inhibitors of CSR3. For monitoring CSR3 activity via HTS, we used a small interfering RNA substrate that was labelled with a FRET‐compatible dye. The optimized HTS assay yielded 109 potential inhibitors of CSR3 out of 6,620 compounds tested from different small‐molecule libraries. The three best inhibitor candidates were validated with a dose–response assay. In addition, a parallel screen of the selected candidates was carried out for a similar class 1 RNase III enzyme from Escherichia coli (EcR3), and this screen yielded a different set of inhibitors. Thus, our results show that the CSR3 and EcR3 enzymes were inhibited by distinct types of molecules, indicating that this HTS assay could be widely applied in drug discovery of class 1 RNase III enzymes. John Wiley and Sons Inc. 2020-05-21 /pmc/articles/PMC7280029/ /pubmed/32436305 http://dx.doi.org/10.1111/mpp.12942 Text en © 2020 The Authors. Molecular Plant Pathology published by British Society for Plant Pathology and John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Wang, Linping
Saarela, Jani
Poque, Sylvain
Valkonen, Jari P.T.
Development of FRET‐based high‐throughput screening for viral RNase III inhibitors
title Development of FRET‐based high‐throughput screening for viral RNase III inhibitors
title_full Development of FRET‐based high‐throughput screening for viral RNase III inhibitors
title_fullStr Development of FRET‐based high‐throughput screening for viral RNase III inhibitors
title_full_unstemmed Development of FRET‐based high‐throughput screening for viral RNase III inhibitors
title_short Development of FRET‐based high‐throughput screening for viral RNase III inhibitors
title_sort development of fret‐based high‐throughput screening for viral rnase iii inhibitors
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280029/
https://www.ncbi.nlm.nih.gov/pubmed/32436305
http://dx.doi.org/10.1111/mpp.12942
work_keys_str_mv AT wanglinping developmentoffretbasedhighthroughputscreeningforviralrnaseiiiinhibitors
AT saarelajani developmentoffretbasedhighthroughputscreeningforviralrnaseiiiinhibitors
AT poquesylvain developmentoffretbasedhighthroughputscreeningforviralrnaseiiiinhibitors
AT valkonenjaript developmentoffretbasedhighthroughputscreeningforviralrnaseiiiinhibitors